The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sklawer Andrew D since 2020.
This trader's CIK number is 1782334.
At the time of last reporting, Sklawer Andrew D was the President and CEO of Fresh Tracks Therapeutics, Inc.. (stock ticker symbol FRTX).
Also see all insider trading activities at Fresh Tracks Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FRTX | 0 | $0 | 0 | $0 | 55,000 | $0 |
| 2021 | FRTX | 15,375 | $12,300 | 0 | $0 | 20,000 | $0 |
| 2020 | FRTX | 13,044 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-02 | FRTX | Option Ex | 55,000 | .00 | 0 |
| 2021-05-17 | BBI | Buy | 15,375 | .80 | 12,300 |
| 2021-03-16 | BBI | Option Ex | 20,000 | .00 | 0 |
| 2020-06-22 | BBI | Buy | 13,044 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sklawer Andrew D (President and CEO of Fresh Tracks Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.